These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6526900)

  • 41. Determination of Escitalopram Oxalate and L-Methylfolate in Tablet by Spectrophotometric and Reverse Phase High-Performance Liquid Chromatographic Methods.
    Sheladia S; Patel B
    J Chromatogr Sci; 2017 May; 55(5):550-555. PubMed ID: 28203815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colorimetric determination of ethinyl estradiol in oral contraceptive formulations.
    Wu JY
    J Assoc Off Anal Chem; 1974 May; 57(3):747-51. PubMed ID: 4833420
    [No Abstract]   [Full Text] [Related]  

  • 43. Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.
    Chambers DM; Jefferson GC; Chambers M; Loudon NB
    Br J Clin Pharmacol; 1982 Feb; 13(2):229-32. PubMed ID: 7059420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oestrogen content of oral contraceptives.
    Lancet; 1969 Dec; 2(7634):1345. PubMed ID: 4188101
    [No Abstract]   [Full Text] [Related]  

  • 45. Analysis of estrogen sulphate mixtures in pharmaceutical formulations by reversed-phase chromatography.
    Flann B; Lodge B
    J Chromatogr; 1987 Jul; 402():273-82. PubMed ID: 3654869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of RP-HPLC and ultraviolet spectrophotometric methods of analysis for the quantitative estimation of antiretroviral drugs in pharmaceutical dosage forms.
    Sarkar M; Khandavilli S; Panchagnula R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):349-54. PubMed ID: 16330261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hormonal contraceptives].
    Carlotti N
    Rev Prat; 2008 Jan; 58(1):21-8. PubMed ID: 18326358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validated RP-HPLC method for determination of permethrin in bulk and topical preparations using UV-vis detector.
    Arayne MS; Sultana N; Hussain F
    J Chromatogr Sci; 2011 Apr; 49(4):287-91. PubMed ID: 21439119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular effects and progestins in oral contraceptives.
    Wynn V
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):718. PubMed ID: 7065052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
    Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
    J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography using solid-phase extraction and ultraviolet detection.
    Chen J; Cai J; Tao W; Mei N; Cao S; Jiang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):201-6. PubMed ID: 16321580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New knowledge in the physiology of hormonal contraceptives.
    Lobo RA; Stanczyk FZ
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isocratic RP-HPLC method for rutin determination in solid oral dosage forms.
    Kuntić V; Pejić N; Ivković B; Vujić Z; Ilić K; Mićić S; Vukojević V
    J Pharm Biomed Anal; 2007 Jan; 43(2):718-21. PubMed ID: 16920326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Essential metals in oral contraceptive tablets.
    Dawson EB; Frey MJ; Monistere N; McGanity WJ
    Am J Obstet Gynecol; 1973 Jun; 116(3):412-4. PubMed ID: 4707542
    [No Abstract]   [Full Text] [Related]  

  • 56. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of foscarnet (trisodium phosphonoformate) in pharmaceutical preparations by high-performance liquid chromatography with ultraviolet detection.
    García J; Márquez A; Ruiz R; López LF; Claro C; Lucero MJ
    Biomed Chromatogr; 2006 Oct; 20(10):1024-7. PubMed ID: 16583452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast cancer and oestrogen content of oral contraceptives.
    Bye P
    Lancet; 1984 Jan; 1(8370):223. PubMed ID: 6141361
    [No Abstract]   [Full Text] [Related]  

  • 59. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.
    Visser J; Snel M; Van Vliet HA
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003990. PubMed ID: 17054193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new universal high-performance liquid chromatographic method for determination of 1,4-benzodiazepines as bulk drugs and in pharmaceutical formulations.
    Kazemifard AG; Javadzadeh N; Gholami K
    Acta Pol Pharm; 2008; 65(2):179-86. PubMed ID: 18666423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.